. Author manuscript; available in PMC: 2019 Sep 1.

Published in final edited form as: Harv Rev Psychiatry. 2018 Sep-Oct;26(5):264–273. doi: 10.1097/HRP.0000000000000190

Table 2.

Benzodiazepine (BZD) use for treatment of anxiety disorders

Anxiety Disorders
Study	N	Age	BZD/Other Treatment	Summary of Findings	Favors BZD
Placebo Controlled
Koepke et al. 1982²⁶	220	Mean 68	Oxazepam 30 to 60 mg Placebo	Oxazepam demonstrated reductions in the Hamilton Anxiety Scale and Physician Target Symptom Scale over placebo	Yes
Vs. Other Treatment
None